[Endoscopic, biopsy and functional results in irradiated esophageal carcinoma].
83 patients of average age 64 (36-86) years with esophageal cancer were irradiated according to a prospectively defined treatment concept. After 60 Gy, re-endoscopy with biopsy was scheduled. If the tumor was still macro- or microscopically described, a boost to 70 Gy was given. During consistent weekly monitoring particular attention was focused on patients' ability to feed themselves. While initially only 7.2% could swallow solid food, by the end 84% of patients with a radiation dose of 60 Gy or more reported normal daily eating. Patients in whom the tumor was no longer present endoscopically or histologically survived four times longer (13.5 months) than those with persistent malignoma.
Kern
T
T
Kantonsspital Aarau.
Remsey
Z
Z
Notter
M
M
Fehr
H
H
Schwegler
N
N
D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D002294:Carcinoma, Squamous Cell / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology; D003679:Deglutition; D004938:Esophageal Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D004945:Esophagoscopy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011859:Radiography; D011879:Radiotherapy Dosage
Endoskopische, bioptische und funktionelle Ergebnisse bestrahlter Osophaguskarzinome.